Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2006-03-17
2010-12-14
Ford, Vanessa L. (Department: 1645)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C536S023700, C530S300000, C424S184100, C424S269100
Reexamination Certificate
active
07851603
ABSTRACT:
A method of preventing or inhibiting infection by a parasite or virus in vivo comprising administering to a human in need thereof a parasite or virus mitogen in a sub-mitogenic amount sufficient to induce a protective immune response against the parasite or virus in the human.
REFERENCES:
patent: 6713617 (2004-03-01), Minoprio et al.
patent: 2005/0090655 (2005-04-01), Minoprio et al.
patent: 2005/0130166 (2005-06-01), Minoprio et al.
patent: 07 289275 (1995-07-01), None
patent: WO 94 25606 (1994-04-01), None
patent: WO 0140449 (2001-06-01), None
patent: WO 0140449 (2001-06-01), None
Chamond et al (The Journal of Biological Chemistry, vol. 278, Issue of May 2, pp. 15484-15494, 2003).
Cook et al (The Journal of Biological Chemistry, vol. 277, No. 31, Aug. 2, 2002, pp. 27782-27792).
Cheng et al (The Journal of Biological Chemistry, vol. 276, No., Feb. 18, 2000, pp. 4906-4911).
Kleppe et al (Tidsskr Nor Laegeforen, Sep. 30, 2001; 121(23):2717-20).Abstract only).
Hoppner (Horm Re. 2002, 58 Suppl. 3:7-15).
Billaut-Mulot et al (Biol. Cell, 1994, 82(1):39-44.).
Wall (Theriogenology, 1996,vol. 45, pp. 57-68).
Houdebine, (J. Biotech. vol. 34, 1994, pp. 269-287, specifically p. 281).
Kappel, (Current Opinions in Biotechnology, vol. 3, 1992, pp. 548-553).
Cameron, (Molec. Biol. 7, 1997, pp. 253-265, specifically p. 256, col. 1 -2, bridg. parag.).
Niemann, (Transg. Res. 7, 1997, pp. 73-75).
Mullins, (Hypertension, vol. 22, 1993, pp. 630-633).
Mullins (Nature, vol. 344, 1990, 541-544).
Hammer (Cell, vol. 63, 1990, 1099-1112).
Mullins (EMBO J., vol. 8, 1989, pp. 4065-4072).
Mullins (J. Clin. Invest. vol. 98, 1996. pp. S37-S40).
Taurog et al, Jour. Immunol., vol. 141, 1988, pp. 4020-4023).
Overbeek (“Factors affecting transgenic animal production,” Transgenic Animal Technology, 1994, pp. 96-98).
Bowie et al (Science, 1990, 257:1306-1310).
McGuinnes et al. (Mol. Microbiol. 7: 505-514, Feb. 1993).
McGuinnes et al. (Lancet 337: 514-517, Mar. 1991).
Stratagene, (Prime-It kit , 1991).
Johnston et al (BioEssays 21:131-147, 199, p. 131-147).
Lodish et al., (Mol. Cell Biol., 3rd ed. Scientific American Books, NY, 1995).
Aguero, et al., “T. cruziEpimastigote Normalized cDNA LibraryTrypanosoma cruzicDNA clone G47H8, Genomic Survey Sequence,” Genbank Accession No. AQ908238, Jan. 9, 2001.
Aguero, et al., “T. cruziEpimastigote Normalized cDNA LibraryTrypanosoma cruzicDNA clone G35A1, Genomic Survey Sequence,” Genbank Accession No. AQ903011, Jan. 9, 2001.
Porcel, et al., “T. cruziEpimastigote Normalized cDNA LibraryTrypanosoma cruzicDNA clone 23b1 5′, mRNA Sequence,” Genbank Accession No. AI057768, Sep. 21, 2000.
Porcel, et al., “T. cruziEpimastigote Normalized cDNA LibraryTrypanosoma cruzicDNA clone 24f18 5′, mRNA Sequence,” Genbank Accession No. AI057684, Sep. 21, 2000.
Porcel, et al., “T. cruziEpimastigote Normalized cDNA LibraryTrypanosoma cruzicDNA clone 18i7 5′, mRNA Sequence,” Genbank Accession No. AI053153, Sep. 21, 2000.
Porcel, et al., “T. cruziEpimastigote Normalized cDNA LibraryTrypanosoma cruzicDNA clone 23d19 5′, mRNA Sequence,” Genbank Accession No. AI057805, Sep. 21, 2000.
Verdun, et al., “T. cruziEpimastigote Normalized cDNA LibraryTrypanosoma cruzicDNA clone 1769 5′, mRNA Sequence,” Genbank Accession No. AA952585, Oct. 29, 1998.
Verdun, et al., “T. cruziEpimastigote Normalized cDNA LibraryTrypanosoma cruzicDNA clone 1816 5′, mRNA Sequence,” Genbank Accession No. AA952632, Oct. 29, 1998.
Verdun, et al., “T. cruziEpimastigote Normalized cDNA LibraryTrypanosoma cruzicDNA clone 500 5′, mRNA Sequence,” Genbank Accession No. AA882923, Oct. 29, 1998.
Verdun, et al., “T. cruziEpimastigote Normalized cDNA LibraryTrypanosoma cruzicDNA clone 2013 5′, mRNA Sequence,” Genbank Accession No. AI562488, Mar. 25, 1999.
Aguillon et al., “Purification and Preliminary Sequencing of Tc45, An ImmunodominantTrypanosoma cruziAntigen: Absence of Homology with Cruzipain, Cruzain, and a 46-Kilodalton Protein,”Am. J. Trop. Med. Hyg., Aug. 1995, pp. 211-215, vol. 53, No. 2.
U.S. Appl. No. 11/388,474, filed Mar. 23, 2006, Minoprio et al.
U.S. Appl. No. 11/378,706, filed Mar. 17, 2006, Minoprio et al.
Billaut-Mulot et al., “Molecular and Immunological Characterization of aTrypanosoma cruziProtein Homologous to Mammalian Elongation Factor 1 Gamma,”Biol. Cell., 1994, pp. 39-44, vol. 82, No. 1.
Chamond, et al., “Biochemical Characterization of Proline Racemases from the Human Protozoan ParasiteTrypanosoma cruziand Definition of Putative Protein Signatures,”J. Biol. Chem., May 2003, pp. 15484-15494, vol. 278, No. 18.
Cheng, et al., “A Eukaryotic Alanine Racemase Gene Involved in Cyclic Peptide Biosynthesis,”J. Biol. Chem., Feb. 2000, pp. 4906-4911, vol. 275, No. 7.
Cook, et al., “Direct Calcium Binding Results in Activation of Brain Serine Racemase,”J. Biol. Chem., Aug. 2002, pp. 27782-27792, vol. 277, No. 31.
Cordeiro Da Silva et al., “A 24 000 MWTrypanosoma cruziantigen is a B-cell activator,”Immunology, Jun. 1998, pp. 189-196, vol. 94, No. 2.
Hoppner, W., “Clinical Impact of Molecular Diagnostics in Endocrinology. Polymorphisms, Mutations and DNA Technologies,”Horm. Res., 2002, pp. 7-15, vol. 58, Suppl. (Abstract Only).
Kabisch et al., “Identification of D-Proline Reductase fromClostridium sticklandiias a Selenoenzyme and Indications for a Catalytically Active Pyruvoyl Group Derived from a Cysteine Residue by Cleavage of a Proprotein,”J. Biol. Chem., Mar. 1999, pp. 8445-8454, vol. 274, No. 13.
Kleppe, et al., “Why Do Mutations Cause Disease—A Protein Chemical Perspective,”Tidsskr. Nor. Laegeforen., Sep. 2001, pp. 2717-2120, vol. 121, No. 23. (Abstract Only).
Stratagene, Prime-It kit, p. 66, from 1991 Product Catalog.
Uo et al., “Occurrence of Pyridoxal 5′-Phosphate-Dependent Serine Racemase in Silkworm,Bombyx mori,” Biochem. Biophys. Res. Commun., May 1998, pp. 31-34, vol. 246, No. 1.
Verdun et al., “Gene Discovery through Expressed Sequence Tag Sequencing inTrypanosoma cruzi,” Infect. Immun., Nov. 1998, pp. 5393-5398, vol. 66, No. 11.
Watabe et al., “Identification and Sequencing of a Gene Encoding a Hydantoin Racemase from the Native Plasmid ofPseudomonassp. Strain NS671,”J. Bactetiol., Jun. 1992, pp. 3461-3466, vol. 174, No. 11.
International Search Report for PCT/IB 00/02008.
Arala-Chaves Mario
Cosson Alain
Coutinho Antonio
Degrave Wim
Fernandes de Almeida, legal representative Sara Isabel Mansinho
Centre National de la Recherche Scientifique
Finnegan Henderson Farabow Garrett & Dunner LLP
Ford Vanessa L.
Instituto Gulbenkian de Cienca
LandOfFree
Cloning, sequencing and expression of a gene encoding an... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cloning, sequencing and expression of a gene encoding an..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cloning, sequencing and expression of a gene encoding an... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4220085